Initial treatment options for relapsed/refractory multiple myeloma patients
Initial treatment options for relapsed/refractory multiple myeloma patients
Latest in advanced endometrial cancer
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021
Paediatric ALL perspective
OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021
WCLC 2021: Epidemiology of MET Exon 14 mutations
OncoAlert and ecancer weekly round up for October 11th - October 16, 2021
ESMO 2021: Latest in EGFR mutated advanced NSCLC
First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and brain metastases: Results From CheckMate 9LA
ESMO 2021: PARPi data and their role in mono/combination therapies
Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLC
ESMO 2021: Breast cancer roundup